HeartWare Warning Letter Cites Quality System Deficiencies
This article was originally published in The Gray Sheet
Executive Summary
The implantable ventricular-assist-device firm said it received a warning letter on June 3 based on an FDA inspection of its Miami Lakes, Florida, manufacturing facility in January.